
Study evaluates cost-effectiveness of olaparib for metastatic pancreatic cancer
Studies have shown that utilising a PARP inhibitor in the management of patients with metastatic…
Studies have shown that utilising a PARP inhibitor in the management of patients with metastatic…
In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers…
Gabrielle Dunlevy, UNSW A streamlined model of education can be used to offer genetic testing…
Researchers at Peter MacCallum Cancer Centre are calling for greater caution in genetic testing for…
By Julia Medew – SMH. If there was ever any doubt about the magnitude of Angelina…
New guidance published by NICE a “game changer” for UK women with genetic risk of…